The economics of the public option: Evidence from local pharmaceutical markets
By: Atal, Juan Pablo et al
.
Material type: 
BookPublisher: The American Economic Review Description: 114(3), Mar, 2024: p.615-644.
In:
The American Economic ReviewSummary: We study the effects of competition by state-owned firms, leveraging the decentralized entry of public pharmacies to local markets in Chile. Public pharmacies sell the same drugs at a third of private pharmacy prices, because of stronger upstream bargaining and market power in the private sector, but are of lower quality. Public pharmacies induced market segmentation and price increases in the private sector, which benefited the switchers to the public option but harmed the stayers. The countrywide entry of public pharmacies would reduce yearly consumer drug expenditure by 1.6 percent.- Reproduced
https://www.aeaweb.org/articles?id=10.1257/aer.20211547
| Item type | Current location | Call number | Vol info | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Articles
|
Indian Institute of Public Administration | 114(3), Mar, 2024: p.615-644 | Available | AR131748 |
We study the effects of competition by state-owned firms, leveraging the decentralized entry of public pharmacies to local markets in Chile. Public pharmacies sell the same drugs at a third of private pharmacy prices, because of stronger upstream bargaining and market power in the private sector, but are of lower quality. Public pharmacies induced market segmentation and price increases in the private sector, which benefited the switchers to the public option but harmed the stayers. The countrywide entry of public pharmacies would reduce yearly consumer drug expenditure by 1.6 percent.- Reproduced
https://www.aeaweb.org/articles?id=10.1257/aer.20211547
There are no comments for this item.